MedPath
NMPA Approval

Belzutifan Tablets

国药准字HJ20240135

November 15, 2024

Drug Information

贝组替凡片

维利瑞

片剂

40mg

化学药品

November 15, 2024

November 14, 2029

Company Information

Applicant Company

120 MOORGATE, LONDON, EC2M 6UR, UNITED KINGDOM

Manufacturing Company

BALLYDINE, KILSHEELAN, CLONMEL, COUNTY TIPPERARY, IE-E91 V091, IRELAND

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

贝组替凡片 - NMPA 批准文号 | MedPath